<DOC>
	<DOCNO>NCT00449839</DOCNO>
	<brief_summary>A pharmacokinetic study insulin pump treatment use Insulin Aspart . The study consist three different period A , B C constant insulin infusion rate give period . In period B C infusion start bolus . It investigate steady state insulin obtain faster period B C A .</brief_summary>
	<brief_title>Changes Infusion Rate Insulin Pump Treatment</brief_title>
	<detailed_description>A pharmacokinetic study insulin pump treatment use Insulin Aspart . The study consist three different period A , B C constant insulin infusion rate give period . Each period last 12 hour blood drawn measure absorb Insulin Aspart . During period A constant infusion rate insulin give . In period B C start constant infusion rate give bolus . The bolus period C calculate basis result period B , therefore participant experience period C last period A B randomize cross-over . Period C write protocol optional evaluated period A B period C perform . The hypothesis steady state insulin obtain faster period B C A .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Informed consent Healthy volunteer Men woman â‰¥18 &lt; 50 year Women childbearing age sufficient protect pregnancy ( use birth control pill intrauterine device sterilize hysterectomized ) BMI 1830 kg/m^2 ( include ) Suspected know allergy drug use study similar drug Previous history endocrinology disease ( include Diabetes Mellitus ) Suspected known alcohol drug abuse Any disease influencing study , evaluate investigator Pregnancy , breastfeed wish become pregnant study period . Furthermore woman child bear age sufficient protect pregnancy ( sufficient : use birth control pill intrauterine device sterilize hysterectomized ) Participation research project last 3 month project</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Insulin pump treatment CSII</keyword>
	<keyword>Absorption</keyword>
	<keyword>Insulin Aspart</keyword>
</DOC>